 Incannex Healthcare Ltd. IXHL, -4.23 shares jumped 7 after the Australia-based cannabinoid and psychedelic compound medicine development company said it would pay 93.3 million to acquire APIRx Pharmaceutical USA LLC, a pharmaceutical medicinal cannabinoid product development company. 